Pages that link to "Q38191280"
Jump to navigation
Jump to search
The following pages link to Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance (Q38191280):
Displaying 10 items.
- Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders (Q27022561) (← links)
- Bone Marrow Homing and Engraftment Defects of Human Hematopoietic Stem and Progenitor Cells (Q33642191) (← links)
- A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat. (Q36006801) (← links)
- Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy (Q39026510) (← links)
- Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies. (Q41010661) (← links)
- Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation (Q41453938) (← links)
- Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies (Q45872216) (← links)
- Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide (Q50073298) (← links)
- Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia (Q57493528) (← links)
- Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy (Q90182599) (← links)